Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II, Randomized, Double-blind, Multicenter, Immunogenicity Study of Vacc-4x Versus Placebo in Patients Infected With HIV-1 Who Have Maintained an Adequate Response to ART

NCT00659789 is registered in ClinicalTrials.gov with Bionor Immuno AS as lead sponsor.

NCT NCT00659789
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00659789 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II, Randomized, Double-blind, Multicenter, Immunogenicity Study of Vacc-4x Versus Placebo in Patients Infected With HIV-1 Who Have Maintained an Adequate Response to ART
Lead sponsor
Bionor Immuno AS
Phase
Phase 2
Overall status
Completed
Start date
August 31, 2008
Completion date
June 30, 2011
Enrollment
137 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

hiv i infection